Cullinan Therapeutics Inc (CGEM)
EBITDA Margin
-356.22%
TTM · Period ending:
CGEM EBITDA Margin
Latest reported-356.22%period ending
Latest reported-356.22%period ending
CGEM TTM EBITDA Margin (-281.69% → -356.22%)
TTM ebitda margin
High-resolution chart · PNG
CGEM ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -356.2213% | |
| -329.6363% | |
| -293.9397% | |
| -281.6924% |